599 Results for "

hER

" in MedChemExpress (MCE) Product Catalog:
Products (599)

599 Results for "hER" in MCE Product Catalog:

  • Targets Recommended:
249
249 Publications Verification
Referencia número: HY-50767
No. CAS: 571190-30-2
Synonyms: PD 0332991
Target:  

CDK

Áreas de investigación:  

Cancer

Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
249
249 Publications Verification
Referencia número: HY-50767A
No. CAS: 827022-32-2
Synonyms: PD 0332991 monohydrochloride
Target:  

CDK

Áreas de investigación:  

Cancer

Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
245
245 Cited Publications
Referencia número: HY-A0065
No. CAS: 827022-33-3
Synonyms: PD 0332991 isethionate
Target:  

CDK

Áreas de investigación:  

Infection Neurological Disease Cancer

Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
229
229 Cited Publications
Referencia número: HY-50767C
No. CAS: 571189-11-2
Synonyms: PD-0332991 hydrochloride
Target:  

CDK

Áreas de investigación:  

Cancer

Palbociclib (PD 0332991) hydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib hydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells. Palbociclib hydrochloride can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma .
loading...
    loading...
111
111 Cited Publications
Referencia número: HY-10261
No. CAS: 850140-72-6
Pureza:  99.92%
Synonyms: BIBW 2992
Áreas de investigación:  

Cancer

Afatinib (BIBW 2992) is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFR wt, EGFR L858R, EGFR L858R/T790M and HER2, respectively. Afatinib can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer .
loading...
    loading...
111
111 Cited Publications
Referencia número: HY-10261A
No. CAS: 850140-73-7
Pureza:  99.74%
Synonyms: BIBW 2992MA2
Áreas de investigación:  

Cancer

Afatinib (BIBW 2992) dimaleate is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFR wt, EGFR L858R, EGFR L858R/T790M and HER2, respectively. Afatinib dimaleate can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer .
loading...
    loading...
66
66 Cited Publications
Referencia número: HY-P9907A
No. CAS: 180288-69-1
Synonyms: Anti-Human hER2, Humanized Antibody (anti-hER2)

Target:  

ADC Antibodies EGFR

Áreas de investigación:  

Cancer

Trastuzumab (anti-HER2) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (anti-HER2) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
loading...
    loading...
66
66 Cited Publications
Referencia número: HY-P9907
No. CAS: 180288-69-1
Synonyms: Anti-Human hER2, Humanized Antibody

Áreas de investigación:  

Cancer

Trastuzumab is a humanized IgG1 monoclonal antibody that selectively binds to HER2 with high affinity. Trastuzumab can be used for the research of HER2-positive metastatic breast cancer and gastric cancer . (Note: The product specifications below only indicate the effective content of Trastuzumab. The component ratio of this product is Trastuzumab : excipients = 1:0.6-1:0.9.)
loading...
    loading...
28
28 Cited Publications
Referencia número: HY-10260
No. CAS: 443913-73-3
Pureza:  99.95%
Synonyms: ZD6474
Target:  

VEGFR Autophagy Apoptosis

Áreas de investigación:  

Neurological Disease Inflammation/Immunology Cancer

Vandetanib (D6474) is a potent, orally active, and blood-brain-barrier penetrate inhibitor of VEGFR2/KDR tyrosine kinase activity (IC50=40 nM). Vandetanib also has activity versus the tyrosine kinase activity of VEGFR3/FLT4 (IC50=110 nM) and EGFR/HER1 (IC50=500 nM) .
loading...
    loading...
27
27 Cited Publications
Referencia número: HY-32721
No. CAS: 698387-09-6
Synonyms: HKI-272
Target:  

EGFR

Áreas de investigación:  

Cancer

Neratinib (HKI-272) is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively .
loading...
    loading...
27
27 Cited Publications
Referencia número: HY-32721B
No. CAS: 915942-22-2
Synonyms: HKI-272 maleate
Target:  

EGFR

Áreas de investigación:  

Cancer

Neratinib (HKI-272) maleate is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively .
loading...
    loading...
24
24 Cited Publications
Referencia número: HY-N0289
No. CAS: 2188-68-3
Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity . Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM) .
loading...
    loading...
19
19 Cited Publications
Referencia número: HY-16069
No. CAS: 937263-43-9
Synonyms: Irbinitinib; ARRY-380; ONT-380
Target:  

EGFR

Áreas de investigación:  

Cancer

Tucatinib (Irbinitinib) is a potent, orally active and selective HER2 inhibitor with an IC50 of 8 nM.
loading...
    loading...
19
19 Cited Publications
Referencia número: HY-16069A
No. CAS: 1429755-56-5
Synonyms: Irbinitinib hemiethanolate; ARRY-380 hemiethanolate; ONT-380 hemiethanolate
Target:  

EGFR

Áreas de investigación:  

Cancer

Tucatinib (Irbinitinib) hemiethanolate is a potent, orally active and selective HER2 inhibitor with an IC50 of 8 nM.
loading...
    loading...
18
18 Cited Publications
Referencia número: HY-104065
No. CAS: 1269662-73-8
Pureza:  99.89%
Synonyms: SHR-1258
Target:  

EGFR

Áreas de investigación:  

Cancer

Pyrotinib (SHR-1258) is a potent and selective EGFR/HER2 dual inhibitor with IC50s of 13 and 38 nM, respectively .
loading...
    loading...
18
18 Cited Publications
Referencia número: HY-104065B
No. CAS: 1397922-61-0
Pureza:  98.01%
Synonyms: SHR-1258 dimaleate
Target:  

EGFR

Áreas de investigación:  

Cancer

Pyrotinib dimaleate (SHR-1258 dimaleate) is a potent and selective EGFR/HER2 dual inhibitor with IC50s of 13 and 38 nM, respectively .
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-13631D
No. CAS: 1599440-33-1
Pureza:  99.30%
Synonyms: Exatecan derivative for ADC
Áreas de investigación:  

Cancer

DXd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a).
loading...
    loading...
12
12 Cited Publications
Referencia número: HY-135815
No. CAS: 1847461-43-1
Pureza:  99.60%
Synonyms: TAK-788; AP32788
Target:  

EGFR

Áreas de investigación:  

Cancer

Mobocertinib (TAK-788) is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib can be used in NSCLC research .
loading...
    loading...
12
12 Cited Publications
Referencia número: HY-135815A
No. CAS: 2389149-74-8
Pureza:  99.83%
Synonyms: TAK-788 succinate; AP32788 succinate
Target:  

EGFR

Áreas de investigación:  

Cancer

Mobocertinib (TAK-788) succinate is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib succinate potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib succinate can be used in NSCLC research .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-P9912A
No. CAS: 380610-27-5

Target:  

EGFR

Áreas de investigación:  

Cancer

Pertuzumab (anti-HER2), a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
loading...
    loading...